Pulmonx Pre-Tax Income 2019-2024 | LUNG
Pulmonx pre-tax income from 2019 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
| Pulmonx Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2023 | $-60 |
| 2022 | $-59 |
| 2021 | $-48 |
| 2020 | $-32 |
| 2019 | $-20 |
| 2018 | $-18 |
| Pulmonx Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-15 |
| 2024-03-31 | $-14 |
| 2023-12-31 | $-14 |
| 2023-09-30 | $-15 |
| 2023-06-30 | $-16 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-14 |
| 2022-09-30 | $-14 |
| 2022-06-30 | $-15 |
| 2022-03-31 | $-16 |
| 2021-12-31 | $-13 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $-13 |
| 2021-03-31 | $-12 |
| 2020-12-31 | $-9 |
| 2020-09-30 | $-4 |
| 2020-06-30 | $-12 |
| 2020-03-31 | $-7 |
| 2019-12-31 | |
| 2019-09-30 | $-4 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.329B | $0.069B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $40.428B | 21.75 |
| Tempus AI (TEM) | United States | $7.918B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.215B | 1157.72 |
| Axonics (AXNX) | United States | $3.513B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.503B | 203.88 |
| 10x Genomics (TXG) | United States | $2.660B | 0.00 |
| Enovis (ENOV) | United States | $2.437B | 17.67 |
| Azenta (AZTA) | United States | $2.413B | 137.03 |
| Privia Health (PRVA) | United States | $2.280B | 158.92 |
| IRhythm Technologies (IRTC) | United States | $2.219B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 64.82 |
| Clover Health Investments (CLOV) | United States | $1.492B | 0.00 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Phreesia (PHR) | United States | $1.389B | 0.00 |
| Standard BioTools (LAB) | United States | $0.753B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.694B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.538B | 456.00 |
| Health Catalyst (HCAT) | United States | $0.529B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.406B | 0.00 |
| Talkspace (TALK) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.286B | 0.00 |
| TruBridge (TBRG) | United States | $0.183B | 13.44 |
| P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| 111 (YI) | China | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.034B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.025B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |